Thromb Haemost 1989; 62(02): 704-707
DOI: 10.1055/s-0038-1646887
Original Article
Schattauer GmbH Stuttgart

Platelet Aggregation Is Stimulated by Lactose-lnhibitable Snake Venom Lectins

Mary L Ogilvie
The Department of Biology Memphis State University Memphis, TN, USA
,
JoAnn Wilson Byl
The Department of Biology Memphis State University Memphis, TN, USA
,
T Kent Gartner
The Department of Biology Memphis State University Memphis, TN, USA
› Author Affiliations
Further Information

Publication History

Received 06 December 1988

Accepted after revision 07 April 1989

Publication Date:
30 June 2018 (online)

Summary

Five lactose-specific lectins from snake venoms were tested for the ability to stimulate the aggregation of human platelets. Three of the lectins, bushmaster (Lachesis muta), cottonmouth (Aricistrodon piscivorous leukostoma) and rattlesnake (Crotalus atrox) lectins, consistently stimulated secretion and aggregation. Thrombolectin (Bothrops atrox) occasionally caused aggregation. Copperhead (Agkistrodon contortrix contortrix) lectin did not by itself cause platelet aggregation. Lactose, a specific inhibitor of hemagglutination mediated by these lectins was a potent inhibitor of lectin-induced aggregation. Antiserum specific for bushmaster lectin inhibited aggregation by bushmaster lectin. In contrast, the same antiserum and anti-cottonmouth lectin serum enhanced aggregation by low levels of the other lectins.

A variety of substances were assayed in the aggregometer for the ability to inhibit aggregation in response to these lectins. Both secretion and aggregation were inhibited by PGI2 and PGEx. Furthermore, lectin-induced aggregation was completely blocked by trifluoperazine and partially blocked by indomethacin. Monoclonal antibodies specific for GP IIb/IIIa (AP2, A2A9, LJP5, LJCP8) but not monoclonals directed against other platelet membrane proteins (API and AP3) inhibited lectin-induced aggregation. The peptide Arg-Gly-Asp-Ser but not Arg-Ala-Asp-Ser was a potent inhibitor of aggregation.

 
  • References

  • 1 Gartner TK, Ogilvie ML. Isolation and characterization of three Ca++-dependent β-galactoside-specific lectins from snake venoms. Biochem J 1984; 224: 301-307
  • 2 Ogilvie ML, Dockter ME, Wenz L, Gartner TK. Isolation and characterization of lactose-binding lectins from the venoms of the snakes Lachesis muta and Dendroaspis jamesonii . J Biochem 1986; 100: 1425-1431
  • 3 Gartner TK, Stocker K, Williams DC. Thrombolectin: A Lectin isolated from Bothrops atrox venom. Febs Lett 1980; 117: 13-16
  • 4 Mastro AM, Hurley DJ, Winning RK, Filipowski R, Ogilvie ML, Gartner TK. Mitogenic activity of snake venom lectins. Cell Tissue Kinet 1986; 19: 557-566
  • 5 Clemetson KJ. Glycoproteins of the platelet plasma membrane. In: Platelet Membrane Glycoproteins. Plenum; New York: 1985: 51-85
  • 6 Ganguly P, Fossett NG. Interaction of lentil lectin with human platelets. Evidence against Glycoprotein II as aggregation mediator. Biochem Biophys Res Commun 1980; 92: 499-504
  • 7 Majerus PW, Brodie GN. The binding of Phytohemmagglutinins to human platelet plasma membranes. J Biol Chem 1972; 247: 4253-4257
  • 8 Ganguly P, Fossett NG. Evidence for multiple mechanisms of interaction between Wheat Germ Agglutinin and human platelets. Biochem Biophys Acta 1980; 627: 256-261
  • 9 Gartner TK, Walz D. Thrombospondin inhibits the expression of the endogenous platelet lectin and alpha-granules. Thromb Res 1983; 29: 63-74
  • 10 Brown TR, Ho TT S, Walz DA. Improved radioimmunoassay of platelet factor 4 and P-Thromboglobulin in plasma. Clin Chim Acta 1980; 101: 225-233
  • 11 Pidard D, Montgomery RR, Bennett JS, Kunicki TJ. Interaction of AP-2, a monoclonal antibody specific for the human platelet glycoprotein IIb/IIIa complex, with intact platelets. J Biol Chem 1983; 258: 12582-12586
  • 12 Bennett JS, Hoxie J, Leitman S, Vilaire G, Cines D. Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody. Proc Natl Acad Sci, USA 1983; 80: 2417-2421
  • 13 Lombardo VT, Hodson E, Roberts JR, Kunicki TJ, Zimmerman TS, Ruggeri ZM. Independent modulation of von Willebrand Factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody. J Clin Invest 1985; 76: 1950-1958
  • 14 Niiya K, Hodson E, Bader R, Byers-Ward V, Koziol JA, Plow EF, Ruggeri ZM. Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation. Relationship to the binding of fibrinogen and platelet aggregation. Blood 1987; 70: 475-483
  • 15 Montgomery RR, Kunicki TJ, Taves C, Pidard D, Corcoran M. Diagnosis of Bemard-Soulier syndrome and Glanzmann's thrombasthenia with a monoclonal assay on whole blood. J Clin Invest 1983; 71: 385-389
  • 16 Newman PJ, Allen RW, Kahn RA, Kunicki TJ. Quantification of membrane platelet glycoprotein Ilia on intact human platelets using the monoclonal antibody AP-3. Blood 1985; 65: 227-232
  • 17 Gartner TK, Bennett JS. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets. J Biol Chem 1985; 260: 11891-11894
  • 18 Plow EF, Pierschbacher MD, Ruoslahti E, Marguerie GA, Ginsberg MH. The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets. Proc Natl Acad Sci, USA 1985; 82: 8057-8061
  • 19 Gartner TK, Ogilvie ML. Peptides and monoclonal antibodies which bind to glycoproteins IIb and/or IIIa inhibit clot retraction. Thromb Res 1988; 49: 43-53
  • 20 White GC, Raynor T. The effects of trifluoperazine, an inhibitor of calmodulin, on platelet function. Thromb Res 1980; 18: 279-284
  • 21 Mustard JF, Packham MA, Kinlough-Rathbone RL, Perry DW, Regoeczi E. Fibrinogen and ADP induced platelet aggregation. Blood 1978; 52: 453-466
  • 22 Tu AT. Venoms: Chemistry and Molecular Biology. John Wiley; New York: 1977: 329-360 and 372-382
  • 23 Huang TF, Holt JC, Lukasiewicz H, Niewiarowski S. Trigramin – A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb/IIIa complex. J Biol Chem 1987; 262: 16157-16163
  • 24 Teng C, Ma Y. Properties of a potent platelet aggregation inhibitor from Echis carinatus snake venom. In: Hemostasis and Animal Venoms. Marcel Dekker; New York: 1988: 399-409
  • 25 Schechter Y, Hemag L, Schlessinger J, Cuatrecasas P. Local aggregation of hormone-receptor complexes is required for activation by epidermal growth factor. Nature 1979; 278: 835-838
  • 26 Jerne NK. The immune system: a web of V-domains. Harvey Lectures 1975; 70: 93-110